Historical record - last NADAC effective date: 10/23/2019
Product Information
NICORETTE 4 MG LOZENGE is a brand product labeled by Haleon US Holdings LLC, priced at $0.4023 per EA under NDC 00135051107. Its NADAC has been published 134 times since Jun 8, 2016.
FDA first approved this application on Oct 31, 2002.
The High Outlier badge above means this manufacturer's average price in the nicotine polacrilex market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4 mg/1
Manufacturer
Haleon US Holdings LLCNDC
00135051107
Classification
Brand
Dosage Form
LOZENGE
Route
ORAL
Effective Date
10/23/2019
Active Ingredients
NICOTINEApproval Type
New Drug (NDA)
FDA Application
NDA021330FDA Approved
10/31/2002
On Market Since
10/19/2010
Pharmacological Classes
Price Statistics
The NADAC for NICORETTE 4 MG LOZENGE has been published 134 times since Jun 8, 2016, and over the history we have for it it has declined 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4023 per EA |
|---|---|
| All-time high | $0.4549 (Oct 12, 2016) |
| All-time low | $0.4023 (Oct 23, 2019) |
| Median price | $0.4505 |
| Average price | $0.4363 |
| Largest weekly change | -11.4% (Oct 23, 2019) |
| Weeks tracked | 134 |
| Tracking since | Jun 8, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.6%
Last surveyed Jul 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nicotine polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICORETTE 4 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for NICORETTE 4 MG LOZENGE, manufactured by Haleon US Holdings LLC, is $0.4023 per EA (NDC 00135051107), effective Jul 1, 2020.
How has the price of NICORETTE 4 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for NICORETTE 4 MG LOZENGE has declined 9.6%. It has been tracked across 134 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for NICORETTE 4 MG LOZENGE?
Since Jun 8, 2016, the NADAC for NICORETTE 4 MG LOZENGE has ranged from a low of $0.4023 (Oct 23, 2019) to a high of $0.4549 (Oct 12, 2016), with a median of $0.4505 per EA.
Are there cheaper alternatives to NICORETTE 4 MG LOZENGE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NICOTINE 4 MG LOZENGE, is $0.3443 per EA — about 14% below NICORETTE 4 MG LOZENGE.
Who manufactures NICORETTE 4 MG LOZENGE?
NICORETTE 4 MG LOZENGE (NDC 00135051107) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.